[Cost-effective PET investigations in oncology]
- PMID: 12368917
[Cost-effective PET investigations in oncology]
Abstract
The authors have reviewed the financial considerations of oncological FDG PET examinations by the guidelines of the Health Care Financing Administration (USA). By critical assessment of large number of clinical investigations,the cost-effectiveness of FDG PET scans has been confirmed in the following cases: differential diagnosis of solitary pulmonary nodule, diagnosis,staging and restaging of non-small cell lung cancer, colorectal cancer, malignant lymphomas, melanoma malignum, esophageal neoplasms and cancers of the head and neck. The role of this method in breast cancer is currently under intensive investigation. Due to the correct staging, PET examinations in these indications enable the clinicians to choose the optimal treatment ensuring the maximum probability of recovery and being cost-effective as unnecessary medical interventions become avoidable.
Similar articles
-
[Cost-effective PET scans in oncology].Orv Hetil. 2002 May 26;143(21 Suppl 3):1255-61. Orv Hetil. 2002. PMID: 12077909 Review. Hungarian.
-
[A proposal for the rational use of the PET in oncology].Rev Esp Med Nucl. 2002 May;21(3):163-73. doi: 10.1016/s0212-6982(02)72056-9. Rev Esp Med Nucl. 2002. PMID: 12206749 Review. Spanish.
-
Clinical applications of PET in oncology.Radiology. 2004 May;231(2):305-32. doi: 10.1148/radiol.2312021185. Epub 2004 Mar 24. Radiology. 2004. PMID: 15044750 Review.
-
Clinical role of positron emission tomography in oncology.Lancet Oncol. 2001 Mar;2(3):157-64. doi: 10.1016/s1470-2045(00)00257-6. Lancet Oncol. 2001. PMID: 11902566 Review.
-
[Positron-emission tomography in oncology].Klin Med (Mosk). 2003;81(12):13-21. Klin Med (Mosk). 2003. PMID: 14971150 Review. Russian.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources